The hydroxychloroquine and ivermectin fiascoes have soured many doctors on repurposing drugs for covid. A few inexpensive old drugs may be as good as some of the new antivirals, but they face complex obstacles to get to patients.
Category: COVID-19
KHN’s ‘What the Health?’: Finally, a Fix for the ‘Family Glitch’
week to announce a new policy for the Affordable Care Act that would make subsidies available to more families with unaffordable employer coverage. Meanwhile, Congress struggled to find a compromise for continued federal funding of covid-19 vaccines, testing, and treatments. Tami Luhby of CNN, Shefali Luthra of The 19th, and Jessie Hellmann of CQ Roll Call join KHN’s Julie Rovner to discuss these issues and more.
A Shortfall of ECMO Treatment Cost Lives During the Delta Surge
About 50% of the covid-19 patients who got the last-ditch life support treatment at Vanderbilt University Medical Center died. Researchers wanted to know what happened to the many patients they had to turn away because ECMO (extracorporeal membrane oxygenation) machines and the specialized staffers needed were in short supply. The grim answer: 90% of those turned away perished.